BioMarin Pharmaceutical shares rise on long-term outlook for genetic disorder treatment
Yahoo/AP
Fri, 08/22/08 - 07:22 pm
FDA rule on drug labeling attracts praise from drugmakers, ire from lawyers
Yahoo/AP
Fri, 08/22/08 - 07:21 pm
Pharma Deals: Start Hostile. Get Friendly.
WSJ Online
Fri, 08/22/08 - 07:20 pm
King Pharma raises pressure on rival
Financial Times
Fri, 08/22/08 - 07:19 pm
Abbott Tries a Crash Diet
Motley Fool
Fri, 08/22/08 - 04:27 pm
Amgen's Nplate Approved by U.S. for Bleeding Disorder
Bloomberg
Fri, 08/22/08 - 03:18 pm
Alpharma shares surge on King buyout offer
Forbes
Fri, 08/22/08 - 03:17 pm
Genentech Ditches Stock Options to Fund $371 Million Retention Plan
WSJ Online
Fri, 08/22/08 - 10:02 am
Merger Watch: APP Pharmaceuticals - Fresenius
Seeking Alpha
Fri, 08/22/08 - 10:01 am
Onyx and Bayer say patients are enrolling in trial of Nexavar for liver cancer
Yahoo/AP
Fri, 08/22/08 - 09:39 am
Eli Lilly's Cymbalta gets expanded European approval as anxiety disorder treatment
Yahoo/AP
Fri, 08/22/08 - 09:36 am
Fresenius Stays Strong in Tough Times
Businessweek
Fri, 08/22/08 - 09:34 am
FDA: Vytorin Not Linked to Cancer Risk
WSJ Online
Fri, 08/22/08 - 09:33 am
King Pharmaceuticals Bids $1.38 Billion for Alpharma
Bloomberg
Fri, 08/22/08 - 09:30 am
The Genentech Guessing Game - What Will Roche Offer Next?
Seeking Alpha
Thu, 08/21/08 - 09:02 pm
DNA analysis heralds a health care revolution
Fortune
Thu, 08/21/08 - 09:01 pm
PDL BioPharma's Partnership Makes Sense
Motley Fool
Thu, 08/21/08 - 05:54 pm
Johnson & Johnson Gets Rejected
Motley Fool
Thu, 08/21/08 - 05:50 pm
Congressmen demand Merck, Schering-Plough supply info on possible Vytorin cancer risk
Yahoo/AP
Thu, 08/21/08 - 05:34 pm
A Gardasil Gotcha
Motley Fool
Thu, 08/21/08 - 05:22 pm

Pages